Today: 1 July 2026
Macquarie shares drop 1.8% as buyback update hits the tape; what to watch next
20 January 2026
1 min read

Macquarie shares drop 1.8% as buyback update hits the tape; what to watch next

SYDNEY, Jan 20, 2026, 17:58 AEDT — After-hours

  • Shares of Macquarie Group fell alongside other Australian financial stocks on Tuesday.
  • The company provided an update on the timetable and progress of its on-market share buyback.
  • Investors are now eyeing a February operational briefing for their next glimpse into trading conditions.

Macquarie Group shares dropped 1.82%, ending Tuesday at A$206.97. The stock underperformed the broader market as bank shares dipped late in the session.

Macquarie’s shift counts as a key signal for Australian financials, known for its liquidity. Tuesday’s trading carried that familiar jittery, risk-averse tone. While the company’s buyback aims to steadily prop up the market, it hasn’t deterred investors from pulling back amid growing macro worries.

The S&P/ASX 200 closed 0.66% lower, dragged down mainly by financials and materials. Financial stocks fell 1.08%, according to the market wrap.

Macquarie on Tuesday filed an update to extend its on-market buy-back program through Nov. 6, 2026. The company plans to repurchase up to A$2 billion worth of ordinary shares and had already acquired roughly A$1.013 billion by Jan. 20.

In a separate filing dated Jan. 19, Macquarie and its controlled entities revealed they were no longer a “substantial holder” in Downer EDI, having fallen below the 5% ownership mark that triggers Australia’s disclosure rules. The form indicated the group dropped below this threshold on Jan. 14. Company Announcements

The wider sentiment has weighed on markets. Global investors are shaken by renewed trade tensions sparked by Washington’s Greenland initiative, fueling what traders dub the “Sell America” trade — a swift exit from U.S. equities, bonds, and the dollar. Reuters

“Fears of prolonged uncertainty, strained alliances, and waning trust in U.S. leadership” are pushing investors to reduce their exposure, Tony Sycamore, a market analyst at IG in Sydney, told Reuters. Reuters

For Macquarie, that tape carries extra weight. The group’s earnings hinge on market volumes, deal flow, and swings in commodities and financing — all sectors that turn volatile quickly when traders dial back risk.

But here’s the catch for those banking heavily on buybacks: they might temper volatility slightly, but they don’t guarantee a floor. If global risk markets take another hit or rate expectations swing wildly, the stock will still behave like a high-beta financial.

Investors are set to focus on Macquarie’s operational briefing scheduled for Feb. 10, with the full-year results due on May 8.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Galderma Shares Drop on FDA Denial of Relfydess Botox Rival
    July 1, 2026, 4:28 AM EDT. Galderma Group AG shares dropped sharply, posting their steepest fall in more than a year after the FDA turned down its Botox competitor Relfydess. Investors sold on news of the decision, worrying about Galderma's push into the Botox segment. The move is a setback for the Swiss company's plans to grow in the cosmetic treatment market.
Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks
Previous Story

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks

OpenAI CFO Sarah Friar lifts lid on $20B revenue run rate as 2026 shifts to “practical adoption”
Next Story

OpenAI CFO Sarah Friar lifts lid on $20B revenue run rate as 2026 shifts to “practical adoption”

Go toTop